Story perspectives

UK backs Ad-Smart Alzheimer’s trial to speed drug discovery

By Drooid · Oct 22, 2026, 10:29 AM UTC · How we work

Summary

Story summary

UK Prime Minister Andy Burnham backed the Ad-Smart Alzheimer’s trial to accelerate drug discovery.
Government funding will first test atomoxetine for ADHD and metformin for diabetes, allowing rapid drop of ineffective drugs.
Up to 20 NHS sites aim to open within 18 months, recruiting over 1,000 patients.
The government reported a 35% cut in trial set-up time, averaging 100 days in the March-year period.

1 of 1

Story summary

UK Prime Minister Andy Burnham backed the Ad-Smart Alzheimer’s trial to accelerate drug discovery.
Government funding will first test atomoxetine for ADHD and metformin for diabetes, allowing rapid drop of ineffective drugs.
Up to 20 NHS sites aim to open within 18 months, recruiting over 1,000 patients.
The government reported a 35% cut in trial set-up time, averaging 100 days in the March-year period.